Literature DB >> 17998336

The SH3 domain of Lck modulates T-cell receptor-dependent activation of extracellular signal-regulated kinase through activation of Raf-1.

Manqing Li1, Su Sien Ong, Bartek Rajwa, Vivian T Thieu, Robert L Geahlen, Marietta L Harrison.   

Abstract

Engagement of the T-cell antigen receptor (TCR) results in the proximal activation of the Src family tyrosine kinase Lck. The activation of Lck leads to the downstream activation of the Ras/Raf/MEK/ERK signaling pathway (where ERK is extracellular signal-related kinase). Under conditions of weak, but not strong, stimulation through the TCR, a version of Lck that contains a single point mutation in the SH3 (Src homology 3) domain (W97ALck) fails to support the activation of ERK, despite initiating signaling through the TCR, as demonstrated by the robust activation of ZAP-70, PLC-gamma, and Ras. We determined that the signaling lesion in W97ALck-expressing cells lies at the level of Raf-1 activation and is dependent on the presence of tyrosines 340/341 in the Raf-1 sequence. These data demonstrate a second function for Lck in TCR-mediated signaling to ERK. Additionally, we found that a significant fraction of Lck is localized to the Golgi apparatus and that, compared with wild-type Lck, W97ALck displays aberrant Golgi membrane localization. Our results support a model where under conditions of weak stimulation through the TCR, in addition to activated Ras, Golgi apparatus-localized Lck is needed for the full activation of Raf-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17998336      PMCID: PMC2223423          DOI: 10.1128/MCB.00150-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  Ras signalling on the endoplasmic reticulum and the Golgi.

Authors:  Vi K Chiu; Trever Bivona; Angela Hach; J Bernard Sajous; Joseph Silletti; Heidi Wiener; Ronald L Johnson; Adrienne D Cox; Mark R Philips
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

2.  Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1.

Authors:  Trever G Bivona; Ignacio Pérez De Castro; Ian M Ahearn; Theresa M Grana; Vi K Chiu; Peter J Lockyer; Peter J Cullen; Angel Pellicer; Adrienne D Cox; Mark R Philips
Journal:  Nature       Date:  2003-06-29       Impact factor: 49.962

Review 3.  Transmembrane adaptor proteins: organizers of immunoreceptor signalling.

Authors:  Václav Horejsí; Weiguo Zhang; Burkhart Schraven
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

4.  Positive and negative regulation of Raf kinase activity and function by phosphorylation.

Authors:  H Chong; J Lee; K L Guan
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

5.  Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.

Authors:  T M Yankee; L M Keshvara; S Sawasdikosol; M L Harrison; R L Geahlen
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

Review 6.  Signal transduction mediated by the T cell antigen receptor: the role of adapter proteins.

Authors:  Lawrence E Samelson
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

7.  T cell receptor signaling precedes immunological synapse formation.

Authors:  Kyeong-Hee Lee; Amy D Holdorf; Michael L Dustin; Andrew C Chan; Paul M Allen; Andrey S Shaw
Journal:  Science       Date:  2002-02-22       Impact factor: 47.728

8.  Adhesion regulation of stromal cell-derived factor-1 activation of ERK in lymphocytes by phosphatases.

Authors:  Tonya Laakko; Rudolph L Juliano
Journal:  J Biol Chem       Date:  2003-06-03       Impact factor: 5.157

9.  Ras activation in Jurkat T cells following low-grade stimulation of the T-cell receptor is specific to N-Ras and occurs only on the Golgi apparatus.

Authors:  Ignacio Perez de Castro; Trever G Bivona; Mark R Philips; Angel Pellicer
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 10.  Mechanisms of regulating the Raf kinase family.

Authors:  Huira Chong; Haris G Vikis; Kun-Liang Guan
Journal:  Cell Signal       Date:  2003-05       Impact factor: 4.315

View more
  8 in total

1.  A PLC-γ1 Feedback Pathway Regulates Lck Substrate Phosphorylation at the T-Cell Receptor and SLP-76 Complex.

Authors:  Judson Belmont; Tao Gu; Ashley Mudd; Arthur R Salomon
Journal:  J Proteome Res       Date:  2017-07-06       Impact factor: 4.466

2.  Type of PaperY192 within the SH2 Domain of Lck Regulates TCR Signaling Downstream of PLC-γ1 and Thymic Selection.

Authors:  Matthias Kästle; Camilla Merten; Roland Hartig; Carlos Plaza-Sirvent; Ingo Schmitz; Ursula Bommhardt; Burkhart Schraven; Luca Simeoni
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

3.  LCK, survivin and PI-3K in the molecular biomarker profiling of oral lichen planus and oral squamous cell carcinoma.

Authors:  Oluwadayo Oluwadara; Luca Giacomelli; Russell Christensen; George Kossan; Raisa Avezova; Francesco Chiappelli
Journal:  Bioinformation       Date:  2009-12-31

4.  Selective regulation of TCR signaling pathways by the CD45 protein tyrosine phosphatase during thymocyte development.

Authors:  Rustom Falahati; David Leitenberg
Journal:  J Immunol       Date:  2008-11-01       Impact factor: 5.422

5.  PD-L1 expression levels on tumor cells affect their immunosuppressive activity.

Authors:  Yang Zheng; You-Chen Fang; Jing Li
Journal:  Oncol Lett       Date:  2019-09-20       Impact factor: 2.967

6.  SMAD4, activated by the TCR-triggered MEK/ERK signaling pathway, critically regulates CD8+ T cell cytotoxic function.

Authors:  Xinwei Liu; Jing Hao; Peng Wei; Xiaohong Zhao; Qiuyan Lan; Lu Ni; Yongzhen Chen; Xue Bai; Ling Ni; Chen Dong
Journal:  Sci Adv       Date:  2022-07-27       Impact factor: 14.957

Review 7.  NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications.

Authors:  Saskia M Leibowitz; Jun Yan
Journal:  Front Mol Neurosci       Date:  2016-09-15       Impact factor: 5.639

8.  Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells.

Authors:  Luca Mologni; Mariantonia Costanza; Geeta Geeta Sharma; Michela Viltadi; Luca Massimino; Stefania Citterio; Stefania Purgante; Hima Raman; Alessandra Pirola; Massimo Zucchetti; Rocco Piazza; Carlo Gambacorti-Passerini
Journal:  Neoplasia       Date:  2018-03-30       Impact factor: 5.715

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.